Nanoform (Finland), an innovative nanoparticle medicine enabling company, today announced it has signed a GMP 1 manufacturing program (clinical development) to enhance TargTex’s Glioblastoma ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback